BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 21865757)

  • 1. Allele-specific gene silencing in osteogenesis imperfecta.
    Ljunggren Ö; Lindahl K; Rubin CJ; Kindmark A
    Endocr Dev; 2011; 21():85-90. PubMed ID: 21865757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allele dependent silencing of collagen type I using small interfering RNAs targeting 3'UTR Indels - a novel therapeutic approach in osteogenesis imperfecta.
    Lindahl K; Kindmark A; Laxman N; Åström E; Rubin CJ; Ljunggren Ö
    Int J Med Sci; 2013; 10(10):1333-43. PubMed ID: 23983594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allele-specific Col1a1 silencing reduces mutant collagen in fibroblasts from Brtl mouse, a model for classical osteogenesis imperfecta.
    Rousseau J; Gioia R; Layrolle P; Lieubeau B; Heymann D; Rossi A; Marini JC; Trichet V; Forlino A
    Eur J Hum Genet; 2014 May; 22(5):667-74. PubMed ID: 24022296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in type I collagen genes resulting in osteogenesis imperfecta in humans.
    Gajko-Galicka A
    Acta Biochim Pol; 2002; 49(2):433-41. PubMed ID: 12362985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteogenesis imperfecta: prospects for molecular therapeutics.
    Forlino A; Marini JC
    Mol Genet Metab; 2000; 71(1-2):225-32. PubMed ID: 11001814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapy approaches for osteogenesis imperfecta.
    Niyibizi C; Wang S; Mi Z; Robbins PD
    Gene Ther; 2004 Feb; 11(4):408-16. PubMed ID: 14724682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allele dependent silencing of COL1A2 using small interfering RNAs.
    Lindahl K; Rubin CJ; Kindmark A; Ljunggren O
    Int J Med Sci; 2008; 5(6):361-5. PubMed ID: 19015742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational spectrum of type I collagen genes in Korean patients with osteogenesis imperfecta.
    Lee KS; Song HR; Cho TJ; Kim HJ; Lee TM; Jin HS; Park HY; Kang S; Jung SC; Koo SK
    Hum Mutat; 2006 Jun; 27(6):599. PubMed ID: 16705691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal diagnosis of osteogenesis imperfecta type I by COL1A1 null-allele testing.
    Nuytinck L; Sayli BS; Karen W; De Paepe A
    Prenat Diagn; 1999 Sep; 19(9):873-5. PubMed ID: 10521849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation analysis of the COL1A1 and COL1A2 genes in Vietnamese patients with osteogenesis imperfecta.
    Ho Duy B; Zhytnik L; Maasalu K; Kändla I; Prans E; Reimann E; Märtson A; Kõks S
    Hum Genomics; 2016 Aug; 10(1):27. PubMed ID: 27519266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel RNA-splicing mutation in COL1A1 gene causing osteogenesis imperfecta type I in a Chinese family.
    Xia XY; Cui YX; Huang YF; Pan LJ; Yang B; Wang HY; Li XJ; Shi YC; Lu HY; Zhou YC
    Clin Chim Acta; 2008 Dec; 398(1-2):148-51. PubMed ID: 18755172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on the evaluation and treatment of osteogenesis imperfecta.
    Harrington J; Sochett E; Howard A
    Pediatr Clin North Am; 2014 Dec; 61(6):1243-57. PubMed ID: 25439022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mutation-independent therapeutic strategem for osteogenesis imperfecta.
    Millington-Ward S; O'Neill B; Kiang AS; Humphries P; Kenna PF; Farrar GJ
    Antisense Nucleic Acid Drug Dev; 1999 Dec; 9(6):537-42. PubMed ID: 10645780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of correlation between the type of COL1A1 or COL1A2 mutation and hearing loss in osteogenesis imperfecta patients.
    Hartikka H; Kuurila K; Körkkö J; Kaitila I; Grénman R; Pynnönen S; Hyland JC; Ala-Kokko L
    Hum Mutat; 2004 Aug; 24(2):147-54. PubMed ID: 15241796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in the COL1A1 and COL1A2 genes associated with osteogenesis imperfecta (OI) types I or III.
    Augusciak-Duma A; Witecka J; Sieron AL; Janeczko M; Pietrzyk JJ; Ochman K; Galicka A; Borszewska-Kornacka MK; Pilch J; Jakubowska-Pietkiewicz E
    Acta Biochim Pol; 2018; 65(1):79-86. PubMed ID: 29543922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal prediction of osteogenesis imperfecta (OI type IV): exclusion of inheritance using a collagen gene probe.
    Tsipouras P; Schwartz RC; Goldberg JD; Berkowitz RL; Ramirez F
    J Med Genet; 1987 Jul; 24(7):406-9. PubMed ID: 2886666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential of gene therapy for treating osteogenesis imperfecta.
    Niyibizi C; Smith P; Mi Z; Robbins P; Evans C
    Clin Orthop Relat Res; 2000 Oct; (379 Suppl):S126-33. PubMed ID: 11039761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteogenesis imperfecta and its molecular diagnosis by determination of mutations of type I collagen genes.
    Tedeschi E; Antoniazzi F; Venturi G; Zamboni G; Tatò L
    Pediatr Endocrinol Rev; 2006 Sep; 4(1):40-6. PubMed ID: 17021582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA sequence analysis in 598 individuals with a clinical diagnosis of osteogenesis imperfecta: diagnostic yield and mutation spectrum.
    Bardai G; Moffatt P; Glorieux FH; Rauch F
    Osteoporos Int; 2016 Dec; 27(12):3607-3613. PubMed ID: 27509835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational analysis of COL1A1 and COL1A2 genes among Estonian osteogenesis imperfecta patients.
    Zhytnik L; Maasalu K; Reimann E; Prans E; Kõks S; Märtson A
    Hum Genomics; 2017 Aug; 11(1):19. PubMed ID: 28810924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.